Engineered glove to evaluate hand disability in rheumatoid arthritis: A pilot-study.


Journal

Joint bone spine
ISSN: 1778-7254
Titre abrégé: Joint Bone Spine
Pays: France
ID NLM: 100938016

Informations de publication

Date de publication:
01 2022
Historique:
received: 25 05 2021
accepted: 01 09 2021
pubmed: 19 9 2021
medline: 7 4 2022
entrez: 18 9 2021
Statut: ppublish

Résumé

The Hand Test System (HTS) is an engineered-sensorized glove that has been originally developed in the neuroscientific field for the evaluation of hand fingers' speed movement. This pilot-study aimed to evaluate the reproducibility of HTS analysis in rheumatoid arthritis (RA), correlating glove-derived parameters with clinical disease activity indexes, self-reported disability-related questionnaires and hand strength. Fifty-five RA patients and fifty age and sex matched healthy controls (HCs) performed HTS analysis. The glove recognized the touch speed between the finger tips during standard sequences of movements, providing three quantitative parameters: touch duration (TD), inter-tapping interval (ITI) and movement rate (MR). These variables were correlated with Health Assessment Questionnaire (HAQ), Health Assessment Questionnaire-Disease Index (HAQ-DI), Hand Disability Index (HDI), Hand Grip Strength (HGS), DAS28-CRP, CDAI and SDAI. Intraclass correlation coefficient was 0.93 (CI: 0.92, 0.95). RA patients showed significantly slower TD, ITI and MR than HCs, for all classes of disease activity (P<0.001). All HTS parameters correlated significantly with HAQ, HAQ-DI, HDI, HGS, DAS28-CRP, SDAI, CDAI (between P<0.05 and P<0.001). Of note, also RA patients in clinical remission showed a significantly higher TD compared with HCs (P<0.001). HTS seems a new safe and fast tool to evaluate rheumatoid hand's functionality, measuring the speed of finger movements. Furthermore, the HTS parameters significantly correlate with quality of life, disease activity, hand strength and perceived hand disability, evaluating also potential hand motor impairment in RA clinical remission.

Identifiants

pubmed: 34536622
pii: S1297-319X(21)00145-7
doi: 10.1016/j.jbspin.2021.105272
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

105272

Informations de copyright

Copyright © 2021 Société française de rhumatologie. Published by Elsevier Masson SAS. All rights reserved.

Auteurs

Massimo Patanè (M)

Internal Medicine Unit, Azienda Sanitaria Locale AL Ospedale Santo Spirito, Casale Monferrato Alessandria, Italy.

Luca Carmisciano (L)

Department of Health Sciences, University of Genova, Genova, Italy.

Elvis Hysa (E)

Laboratory of Experimental Rheumatology and Academic Division of Clinical Rheumatology, Department of Internal Medicine and Specialties (DIMI), University of Genova, IRCCS Rheumatology Unit, San Martino Polyclinic, Viale Benedetto XV, No. 6, 16132 Genova, Italy.

Emanuele Gotelli (E)

Laboratory of Experimental Rheumatology and Academic Division of Clinical Rheumatology, Department of Internal Medicine and Specialties (DIMI), University of Genova, IRCCS Rheumatology Unit, San Martino Polyclinic, Viale Benedetto XV, No. 6, 16132 Genova, Italy.

Alberto Sulli (A)

Laboratory of Experimental Rheumatology and Academic Division of Clinical Rheumatology, Department of Internal Medicine and Specialties (DIMI), University of Genova, IRCCS Rheumatology Unit, San Martino Polyclinic, Viale Benedetto XV, No. 6, 16132 Genova, Italy.

Sabrina Paolino (S)

Laboratory of Experimental Rheumatology and Academic Division of Clinical Rheumatology, Department of Internal Medicine and Specialties (DIMI), University of Genova, IRCCS Rheumatology Unit, San Martino Polyclinic, Viale Benedetto XV, No. 6, 16132 Genova, Italy.

Vanessa Smith (V)

Department of Internal Medicine, Ghent University, Department of Rheumatology, University Hospital, Ghent, Belgium; Unit for Molecular Immunology and Inflammation, VIB Inflammation Research Center (IRC), Ghent, Belgium.

Maurizio Cutolo (M)

Laboratory of Experimental Rheumatology and Academic Division of Clinical Rheumatology, Department of Internal Medicine and Specialties (DIMI), University of Genova, IRCCS Rheumatology Unit, San Martino Polyclinic, Viale Benedetto XV, No. 6, 16132 Genova, Italy. Electronic address: mcutolo@unige.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH